Download PDF
Klinische Neurophysiologie 2023; 54(01): 14-21
DOI: 10.1055/a-2012-2736
Übersicht

Differenzialdiagnose der Amyotrophen Lateralsklerose in der klinischen Praxis

Differential Diagnosis of Amyotrophic Lateral Sclerosis in Clinical Practice
Christine Herrmann
1   Neurology, University of Ulm, Ulm, Germany
,
Johannes Dorst
1   Neurology, University of Ulm, Ulm, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Die Diagnose der Amyotrophen Lateralsklerose (ALS) beruht vorwiegend auf klinischen Kriterien und kann aufgrund des heterogenen Erscheinungsbildes gerade in frühen Krankheitsstadien mitunter schwierig sein. Wegweisend sind der Nachweis einer kombinierten Pathologie des oberen und unteren Motoneurons, der fokale Onset, das Ausbreitungsmuster (Spreading), das typische Verteilungsmuster der Paresen, das Vorhandensein oder Fehlen nicht-motorischer Zusatzsymptome sowie Art und Geschwindigkeit der Krankheitsprogredienz. Dieser Review stellt Charakteristika der ALS sowohl im Hinblick auf die klinische Untersuchung als auch apparativer Zusatzdiagnostik in Abgrenzung zu den wichtigsten Differenzialdiagnosen in Form von Einschlusskörperchenmyositis, Chronisch Inflammatorischer Demyelinisierender Polyneuropathie (CIDP), Mulifokaler Motorischer Neuropathie (MMN), adulter Form der Spinalen Muskelatrophie (SMA), Kennedy-Syndrom und Hereditärer Spastischer Paralyse (HSP) dar.

Abstract

Diagnosis of Amyotrophic Lateral Sclerosis (ALS) relies mainly on clinical criteria and may be difficult in early disease stages due to the heterogenous presentation of the disease. Important features are the combined pathology of upper and lower motor neuron, focal onset, spreading, typical patterns of pareses, the lack or presence of additional non-motoric symptoms, as well as the temporal development of symptoms and disease progression. This review presents the characteristics of ALS related to clinical findings as well as instrumental diagnostics in contrast to its most important differential diagnoses including Inclusion Body Myositis (IBM), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), adult forms of Spinal Muscular Atrophy (SMA), Kennedy Syndrome, and Hereditary Spastic Paraplegia (HSP).

Schlüsselwörter

Amyotrophe Lateralsklerose - Differenzialdiagnose - Klinische Zeichen

Key words

Amyotrophic Lateral Sclerosis - differential diagnosis - clinical features


Publication History

Article published online:
14 March 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Roman GC. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. Journal of neurology, neurosurgery, and psychiatry 1996; 61: 131-137
    CrossrefPubMedGoogle Scholar
  • 2 Uenal H, Rosenbohm A, Kufeldt J. et al. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany – completeness of the ALS registry Swabia. PloS one 2014; 9: e93932 DOI: 10.1371/journal.pone.0093932.
    CrossrefPubMedGoogle Scholar
  • 3 Brettschneider J, Del Tredici K, Toledo JB. et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Annals of neurology 2013; 74: 20-38 DOI: 10.1002/ana.23937.
    CrossrefPubMedGoogle Scholar
  • 4 Braak H, Brettschneider J, Ludolph AC. et al. Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nature reviews Neurology 2013; 9: 708-714 DOI: 10.1038/nrneurol.2013.221.
    CrossrefPubMedGoogle Scholar
  • 5 Ravits J. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Experimental neurology 2014; 262 Pt B 121-126 DOI: 10.1016/j.expneurol.2014.07.021.
    CrossrefPubMedGoogle Scholar
  • 6 Brooks BR, Miller RG, Swash M. et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron. Diseases 2000; 1: 293-299
    PubMedGoogle Scholar
  • 7 de Carvalho M, Dengler R, Eisen A. et al. Electrodiagnostic criteria for diagnosis of ALS. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 2008; 119: 497-503
    CrossrefPubMedGoogle Scholar
  • 8 Ludolph A, Drory V, Hardiman O. et al A revision of the El Escorial criteria – 2015. Amyotrophic lateral sclerosis & frontotemporal degeneration 2015; DOI: 10.3109/21678421.2015.1049183. 1-2 10.3109/21678421.2015.1049183
    CrossrefPubMedGoogle Scholar
  • 9 Shefner JM, Al-Chalabi A, Baker MR. et al. A proposal for new diagnostic criteria for ALS. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 2020; 131: 1975-1978
    CrossrefPubMedGoogle Scholar
  • 10 Rosenbohm A, Liu M, Nagel G. et al. Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany. Journal of neurology 2018; 265: 774-782
    CrossrefPubMedGoogle Scholar
  • 11 Peter RS, Rosenbohm A, Dupuis L. et al. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol 2017; 32: 901-908
    CrossrefPubMedGoogle Scholar
  • 12 Kandler K, Witzel S, Eder K. et al Phenotyping of the thoracic-onset variant of amyotrophic lateral sclerosis: J Neurol Neurosurg Psychiatry 2022; 93: 563-565 DOI: 10.1136/jnnp-2021-326712.. Epub 2021 Oct 19
    CrossrefPubMed
  • 13 Münch M, Müller HP, Behler A. et al. Segmental alterations of the corpus callosum in motor neuron disease: A DTI and texture analysis in 575 patients. Neuroimage Clin 2022; 35: 28
    CrossrefPubMedGoogle Scholar
  • 14 Wu RH, Bruening R. Comparison of Diffusion-Weighted MR Imaging and T2-Weighted MR Imaging in Patients with Amyotrophic Lateral Sclerosis. Neuroradiol J 2007; 19: 705-710
    CrossrefPubMedGoogle Scholar
  • 15 Steinacker P, Feneberg E, Weishaupt J. et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. Journal of neurology, neurosurgery, and psychiatry 2016; 87: 12-20 DOI: 10.1136/jnnp-2015-311387.
    CrossrefPubMedGoogle Scholar
  • 16 Kmezic I, Samuelsson K, Finn A. et al. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies. European journal of neurology: the official journal of the European Federation of Neurological Societies 2022; 29: 2810-2822
    CrossrefPubMedGoogle Scholar
  • 17 Rosenbohm A, Peter RS, Erhardt S. et al. Epidemiology of amyotrophic lateral sclerosis in Southern Germany. Journal of neurology 2017; 264: 749-757
    CrossrefPubMedGoogle Scholar
  • 18 Miller T, Cudkowicz M. Results from the Phase 3 VALOR study and its open-label extension: evaluating the clinical efficacy and safety of tofersen in adults with ALS and confirmed SOD1 mutation. American Neurological Association Annual Meeting. 2021
    PubMedGoogle Scholar
  • 19 Müller K, Brenner D, Weydt P. et al. Comprehensive analysis of the mutation spectrum in 301 German ALS families. Journal of neurology, neurosurgery, and psychiatry 2018; 89: 817-827
    CrossrefPubMedGoogle Scholar
  • 20 Turner MR, Talbot K. Primary lateral sclerosis: diagnosis and management. Pract Neurol 2020; 20: 262-269
    CrossrefPubMedGoogle Scholar
  • 21 Wais V, Rosenbohm A, Petri S. et al. The concept and diagnostic criteria of primary lateral sclerosis. Acta neurologica Scandinavica 2017; 136: 204-211
    CrossrefPubMedGoogle Scholar
  • 22 Hübers A, Hildebrandt V, Petri S. et al. Clinical features and differential diagnosis of flail arm syndrome. Journal of neurology 2016; 263: 390-395
    CrossrefPubMedGoogle Scholar
  • 23 Wijesekera LC, Mathers S, Talman P. et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009; 72: 1087-1094 DOI: 10.1212/01.wnl.0000345041.83406.a2.
    CrossrefPubMedGoogle Scholar
  • 24 Joy JL, Oh SJ, Baysal AI. Electrophysiological spectrum of inclusion body myositis. Muscle & nerve 1990; 13: 949-951
    CrossrefPubMedGoogle Scholar
  • 25 Chiò A, Cocito D, Bottacchi E. et al. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. Journal of neurology, neurosurgery, and psychiatry 2007; 78: 1349-1353
    CrossrefPubMedGoogle Scholar
  • 26 Grimm A, Décard BF, Axer H. et al. The Ultrasound pattern sum score - UPSS. A new method to differentiate acute and subacute neuropathies using ultrasound of the peripheral nerves. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 2015; 126: 2216-2225
    CrossrefPubMedGoogle Scholar
  • 27 Querol L, Devaux J, Rojas-Garcia R. et al. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications. Nature reviews Neurology 2017; 13: 533-547
    CrossrefPubMedGoogle Scholar
  • 28 Querol L, Siles AM, Alba-Rovira R. et al. Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy. Sci Rep 2017; 7: 017-14853
    CrossrefPubMedGoogle Scholar
  • 29 Dorst J, Ludolph AC, Senel M. et al. Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients. Journal of neurology 2018; 265: 2906-2915
    CrossrefPubMedGoogle Scholar
  • 30 Alaedini A, Sander HW, Hays AP. et al. Antiganglioside antibodies in multifocal acquired sensory and motor neuropathy. Archives of neurology 2003; 60: 42-46
    CrossrefPubMedGoogle Scholar
  • 31 Yeh WZ, Dyck PJ, van den Berg LH. et al. Multifocal motor neuropathy: controversies and priorities. Journal of neurology, neurosurgery, and psychiatry 2020; 91: 140-148
    CrossrefPubMedGoogle Scholar
  • 32 Swash M. Reading the palm with MUNIX: A 'reversed split hand' in spinal muscular atrophy: Clin Neurophysiol 2019; 130: 305-306 DOI: 10.1016/j.clinph.2018.11.015.. Epub 2018 Dec 5
    CrossrefPubMed
  • 33 Wurster CD, Steinacker P, Günther R. et al. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen. Journal of neurology 2020; 267: 36-44
    CrossrefPubMedGoogle Scholar
  • 34 Hagenacker T, Wurster CD, Günther R. et al. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Lancet neurology 2020; 19: 317-325
    CrossrefPubMedGoogle Scholar